HD CAG-correlated gene expression changes support a simple dominant gain of function

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Huntington's disease (HD) pathogenesis involves a CAG repeat expansion in the huntingtin gene, leading to a polyglutamine tract.
• The precise mechanism of HD, whether simple gain-of-function or combined gain/loss-of-function, remains debated.

Purpose of the Study:

• To differentiate between simple gain-of-function and complex gain/loss-of-function mechanisms in HD.
• To identify gene expression changes correlated with CAG repeat size and compare them to those in huntingtin-null cells.

Main Methods:

• Utilized heterozygous CAG knock-in mouse embryonic stem (ES) cell lines with varying CAG lengths (Q20/7 to Q111/7).
• Compared genome-wide gene expression profiles between these HD models and huntingtin-null (Hdh(ex4/5/ex4/5)) versus wild-type (Hdh(Q7/7)) ES cells.
• Analyzed shared and distinct pathways affected by CAG length and huntingtin deficiency.

Main Results:

• Identified 73 genes with expression varying continuously with CAG length, showing minimal overlap with 754 genes affected in huntingtin-null cells.
• Found 13 shared pathway categories at the network level between CAG length-correlated and huntingtin-null gene sets.
• Observed distinct yet interconnected metabolic pathways (energy, lipid/sterol/lipoprotein) affected by CAG size versus huntingtin absence.

Conclusions:

• Gene expression alterations in HD are primarily driven by a gain-of-function mechanism related to polyglutamine size.
• CAG-correlative gene expression analysis is a valuable approach to uncover huntingtin's effects.
• Therapeutic strategies targeting HD may need to focus on disease triggers rather than solely huntingtin suppression.